NVO - Novo Nordisk
81.37
0.340 0.418%
Share volume: 31,984
Last Updated: Wed 22 Jan 2025 03:30:07 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.21%
PREVIOUS CLOSE
CHG
CHG%
$81.03
0.34
0.42%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |